Amgen Inc Stock Alpha and Beta Analysis

AMGN Stock  USD 273.94  2.44  0.88%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Amgen Inc. It also helps investors analyze the systematic and unsystematic risks associated with investing in Amgen over a specified time horizon. Remember, high Amgen's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Amgen's market risk premium analysis include:
Beta
0.84
Alpha
(0.23)
Risk
1.39
Sharpe Ratio
(0.18)
Expected Return
(0.25)
Please note that although Amgen alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., NYSE Composite index.) So in this particular case, Amgen did 0.23  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Amgen Inc stock's relative risk over its benchmark. Amgen Inc has a beta of 0.84  . As returns on the market increase, Amgen's returns are expected to increase less than the market. However, during the bear market, the loss of holding Amgen is expected to be smaller as well. At this time, Amgen's Price Book Value Ratio is very stable compared to the past year. As of the 1st of May 2024, Price Fair Value is likely to grow to 25.96, while Book Value Per Share is likely to drop 10.26.

Enterprise Value

53.94 Billion

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Amgen Backtesting, Amgen Valuation, Amgen Correlation, Amgen Hype Analysis, Amgen Volatility, Amgen History and analyze Amgen Performance.

Amgen Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Amgen market risk premium is the additional return an investor will receive from holding Amgen long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Amgen. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Amgen's performance over market.
α-0.23   β0.84

Amgen expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Amgen's Buy-and-hold return. Our buy-and-hold chart shows how Amgen performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Amgen Market Price Analysis

Market price analysis indicators help investors to evaluate how Amgen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Amgen shares will generate the highest return on investment. By understating and applying Amgen stock market price indicators, traders can identify Amgen position entry and exit signals to maximize returns.

Amgen Return and Market Media

The median price of Amgen for the period between Thu, Feb 1, 2024 and Wed, May 1, 2024 is 276.59 with a coefficient of variation of 5.21. The daily time series for the period is distributed with a sample standard deviation of 14.66, arithmetic mean of 281.42, and mean deviation of 11.03. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
 
Amgen dividend paid on 7th of March 2024
03/07/2024
1
Disposition of 2508 shares by Matthew Busch of Amgen at 235.97 subject to Rule 16b-3
04/12/2024
2
Can This High-Yield Dividend Stock Keep Beating the SP 500
04/17/2024
3
A pullback in this biotech stock has created a buying opportunity, according to the charts
04/22/2024
4
Better Buy Pfizer vs. Viking Therapeutics
04/23/2024
5
Verum Partners LLC Top Holdings and 13F Report
04/24/2024
6
Study Women with heart disease prescribed cholesterol-lowering drugs less often than men
04/25/2024
7
AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY
04/26/2024
8
Amgen court hearing in patent lawsuit vs Sandoz over generic Prolia cancelled
04/29/2024
9
Disposition of 1753 shares by Matthew Busch of Amgen at 230.92 subject to Rule 16b-3
04/30/2024

About Amgen Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Amgen or other stocks. Alpha measures the amount that position in Amgen Inc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Dividend Yield0.03130.02970.02960.0182
Price To Sales Ratio4.945.375.479.47

Amgen Upcoming Company Events

As portrayed in its financial statements, the presentation of Amgen's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Amgen's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Amgen's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Amgen. Please utilize our Beneish M Score to check the likelihood of Amgen's management manipulating its earnings.
6th of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Amgen

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:
Check out Amgen Backtesting, Amgen Valuation, Amgen Correlation, Amgen Hype Analysis, Amgen Volatility, Amgen History and analyze Amgen Performance.
Note that the Amgen Inc information on this page should be used as a complementary analysis to other Amgen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Complementary Tools for Amgen Stock analysis

When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Commodity Directory
Find actively traded commodities issued by global exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Amgen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Amgen technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Amgen trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...